case report
A myloidosis is a heterogeneous group of disorders in which amyloid substances are deposited extracellularly. It can be systemic or localized when affecting specific organs. 1 Localized amyloid deposition in the urinary tract, especially of the ureter, is rare; the renal pelvis and bladder are the most common locations found clinically and radiologically. It is extremely difficult to clearly diagnose this disease preoperatively. Few cases of ureteral amyloidosis have been described. We present a case of localized ureteral amyloidosis and a comprehensive review of the literature. Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Case report
A 55-year-old woman was admitted to hospital with complaints of loin pain and painless gross hematuria for 2 days.
She had no history of urologic or chronic medical disorders. A physical examination showed slight tenderness and percussion pain in the left kidney district. All routine examinations were normal, except for hematuria and proteinuria. Cystoscopy performed during a period of hematuria showed bleeding from the left ureter. No tumours or stones were seen in the bladder. Ultrasound scanning demonstrated left hydronephrosis, hydroureter of the proximal-middle portion and obstruction of the lower ureter.
On un-enhanced computed tomography (CT), focal calcification (457 Hounsfield unity [HU]) was present on the ureter wall in the fourth vertebral level (Fig. 1 ) and a homogeneous soft tissue density mass (31-45 HU) was seen in the fifth vertebral level of the left ureter (Fig. 2) . The length of lesion was about 22 mm. Enhanced images showed a strip soft tissue density showing significant enhancement (44 HU) . The length of the lesion was 85 mm (Fig. 3) . No ureteral expansion was present below the distal lesion. Ureteral carcinoma was suspected, and radical left nephroureterectomy was scheduled. However, a perioperative frozen section examination showed the presence of amyloid. It was inevitable to perform nephrostomy if we chose a ureteral tumour resection because of long segment of the tumour. The patient finally elected to undergo left nephroureterectomy after our discussion with her and her family.
Grossly, the segment of the ureter was diffusely thickened and mildly rigid. Histology of the cross-section of the ureter revealed markedly thickened ureteric walls due to amorphous, pale eosinophilic, extracellular nodular deposits expanding the lamina propria and extending patchily into the muscularis propria as well as focally into the adventitia. The amorphous material exhibited apple-green birefringence under polarized light on Congo-red staining (Fig. 4) , indicative of amyloidosis. No follow-up information was available for this patient.
Discussion
Amyloidosis has an incidence of 8 per million people each year. 2 The two major types include primary and secondary. 3 Most cases of primary amyloidosis may be defined as amyloid immunoglobulin light chain (AL) disease. Primary AL amyloidosis has clonal B-cell dyscrasia, including multiple myelomas, B-cell lymphoma, Waldenström macroglobulinemia, or another plasma cell neoplasia. 3, 4 Bone marrow biopsy is required for all patients with AL amyloidosis to exclude overt multiple myeloma. Secondary amyloidosis most often arises as a complication of an underlying chronic inflammatory disease, such as rheumatoid arthritis, Crohn disease, tuberculosis, bronchiectasis, and chronic osteomyelitis. Other rare hereditary and senile forms of amyloidosis have also been described. 2, 5 Amyloidosis may be classified as localized with involvement of 1 organ or systemic with involvement of multiple sites according to the distribution of amyloid deposits. Localized disease is present in about 10% to 20% and most amyloidosis is systemic. 2 The therapeutic approaches and prognostic implications are different. Systemic amyloidosis is progressive and usually fatal; however, supportive or localized management is suitable for localized disease. Systemic amyloidosis usually involves gastrointestinal tract, cardiac and striated muscle and adipose tissue. In the localized type of disease, abnormal proteins are confined to an organ, commonly the respiratory tract, skin or urinary tract. Localized amyloidosis is usually primary, but it can also be secondary, although this is rare. 2, 3 Primary localized amyloidosis of the urinary tract is a rare condition and most of the reported cases have involved the bladder. We searched English articles for MEDLINE database using the key words "ureter amyloidosis" to select papers. 86 papers were found. Based on English articles or English abstract, 45 papers 1-45 and 49 cases of ureteral amyloidosis were matched. Lehmann reported the first case of localized amyloidosis of ureter in 1937. Gilbert and McDonald reported the first English literature about localized ureteric amyloidosis in 1952. 6 The mean age at diagnosis of the reported cases was 58.3, and ranged from 17 to 81. Of these cases, 72.9 % (35/48) of patients were over 50 years old. Women were predominantly affected (32:17) . The main presenting features in 30 patients (61.2%) were loin pain. Twenty-five patients (53.1%) were referred to hospital following hematuria. Among all cases, 7 patients (14.3%) were bilateral. The ratio of left lesion versus right lesion was 19:24. The location of lesion was definite in 44 patients (49 sides), among which, 63.3 % (31/49) were in lower ureter. The remaining was 22.4% and 14.3% in upper ureter and middle ureter, respectively.
Although radiological examinations, such as CT scan, intravenous pyelography and ultrasound, could detect hydronephrosis in all of the above cases, they did not indicate a specific etiology. Some authors consider the presence of calcifications as a typical sign on CT scan and intravenous pyelography. 2 However, only 9 cases (18.4%) showed calcifications on radiological findings. Moreover, calcifications can also be present in tuberculosis and schistosomiasis. 41 Tsujioka and colleagues emphasized that ureteral amyloidosis should be considered when the lesion is visualized as a hypo-intensity on T2-weighted images and is not obviously associated with a mass effect; although it is noteworthy that these authors only have 2 cases in their study. 45 The diagnosis of amyloid is currently based on specific Congo red staining on a biopsy of an involved organ by light microscopy under polarized light. Characteristically, the amyloid deposit shows apple-green birefringence under polarized light when stained with Congo red. The histopathologic diagnosis included AL localized amyloidosis, AA-type amyloidosis, TTR-type amyloidosis, AH type amyloidosis, Aβ type amyloidosis. It is histochemically possible to differentiate the specific protein that makes up the amyloid by treatment with potassium permanganate (KMnO4), if the deposits persist it is AL and if they disappear it is AA. If there are still doubts, it is possible to resort to immunohistochemical techniques or the electron microscope. 4 Immunohistochemistry, however, can give false-negative results. 5 Because of its non-specific features, the first macroscopic diagnosis is often urothelial carcinoma. The treatment in 52 sides (47 cases) was definitely clear in all 49 cases. 5 Surgery was the first choice (47 sides), among which nephroureterectomy was 61.7 % (26/47) and it was the predominant treatment. The reasons of a higher rate of nephroureterectomy were mainly because the ureteral tumour was difficult to exclude before and at surgery, and partly because the involved ureter was too extensive to salvage the ipsilateral kidney by conventional surgery. Biopsies via an ureteroscope prior to surgery or intra-operative frozen section were taken in 16 sides (34.0%, 16/47) enabling the patient to be treated with other surgery instead of nephroureterectomy. The other surgery included ureteroneocystostomy (21.3%, 10/47), local excision and end anastomosis of the ureter (6.4%, 3/47), ileopyelostomy (2.1%, 1/47), autotransplantation (2.1%, 1/47), ileal ureter (2.1%, 1/47), double J stent (2.1%, 1/47), ureteric re-implantation with psoas hitch (2.1%, 1/47). For bilateral localized amyloidosis, correct preoperative diagnosis was necessary to preserve the kidney.
After confirming the pathology by biopsy, Kato and colleagues 35 and Tsuijioka and colleagues 45 treated 3 patients by gauze-dipped dimethyl sulfoxide (DMSO) applied to the skin and oral colchicine. Another non-surgery treatment was follow-up. Tudor Borza and colleagues reported 2 cases with surveillance imaging and routine follow-up, without any medical or surgical interventions. 3 With follow-up of 15 months, 6 years, and 8 years, none of the patients displayed clinical or radiographic signs of progressive disease.
The pathogenesis of localized amyloidosis is unknown, but may be caused by chronic and recurrent inflammation with migration of lymphoplasmic cells and subsequent aberrant monoclonal proliferation and local secretion of light chains. 3 Borza and colleagues found that the prognosis of localized amyloidosis was good. None of the patients developed progressive disease or recurrence of their symptoms during follow-up. 3 Only Mullin and colleagues reported 1 case of ureteral amyloidosis associated with low-grade transitional cell carcinoma. 19 Subsequent follow-up was also uneventful.
Conclusion
Localized amyloidosis of the urinary tract is a rare disease and can easily be confused with a neoplasm. The physiopathology is unknown and the prognosis is usually good. Because of its rarity and the difficulty in differentiating this condition from urothelial carcinoma by clinical manifestation and radiological images, nephroureterectomy has often been performed unnecessarily for this disease. Biopsies via a ureteroscope prior to surgery or intraoperative frozen section examination, which yielded the diagnosis of amyloidosis, could help avoid unnecessary surgery. The use of dimethyl sulfoxide or follow-up with serial imaging may become a promising treatment. Localized amyloidosis of the ureter
